[250 Pages Report] The global demand for hospital supplies is expected to increase at 3.7% CAGR over the forecast period from 2022 to 2032. Sales in the hospital supplies market are estimated to reach a valuation of US$ 29.5 Billion in 2022. According to the study, hospitals held a substantial share of 47.2% in 2021 in the global hospital supplies market.
| Data Points | Market Insights |
|---|---|
| Hospital Supplies Market Value 2021 | US$ 28.6 Billion |
| Hospital Supplies Market Value 2022 | US$ 29.5 Billion |
| Hospital Supplies Market Value 2032 | US$ 42.3 Billion |
| Hospital Supplies Market CAGR 2022 to 2032 | 3.7% |
| Market Share of Top 5 Countries | 53.3% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to Future Market Insights (FMI), the overall sales of hospital supplies grew at a CAGR of 3.3% between 2017 and 2021. However, the demand in the hospital supplies market is expected to increase at a CAGR of 3.5%, reaching US$ 42.3 Billion by the end of 2032.
The global hospital supplies market held around 20% of the global medical supplies market which was valued at nearly US$ 138 Billion in the year 2021.
Hospital settings and other healthcare units are at a greater risk of infections and viral exposure, resulting in a rising prevalence of hospital-acquired infections for over a decade. Several measures are being considered to prevent and reduce the prevalence rate such as the use of disposable procedure kits and trays, sterile and disposable products, sterile medical devices, disposable gloves, and other disposable medical supplies.
For instance, in March 2022, Becton, Dickinson & Company launched a TCR/BCR multi-omic assay which aids in speeding the discovery of infectious diseases, autoimmune disorders, and immune-oncology as well.
According to a survey conducted by CDC, in 2019, about 1 in 31 patients had at least one healthcare-associated infection. In addition, it is also noticed that the prevalence rate of hospital-acquired infections in low-income countries is far higher than in high-income countries.
For instance, a study published in the International Journal of Research and Public Health in 2020 states that a 7.5% prevalence of hospital-acquired infection was observed in high-income countries, although others have reported rates of 4.5% in the USA and 5.7%-7.1% in Europe, while in low- and middle-income countries, however, the prevalence rate ranged between 5.7% and 19.2%.
The hospital supplies market includes different product types such as wound care products, dialysis products, sterilization consumables, infusion products, and hypodermic and radiology products amongst others.
Based on product, hypodermic and radiology products like syringes, needles and consumable products for radiography and ultrasound were the dominant market segment in the global market in 2021, which contributed 17.6% of the revenue share.
The global hospital supplies market is expected to be valued at US$ 42.3 Billion by the end of 2032, registering a CAGR of 3.7% over the forecast period.
Growing awareness regarding health & hygiene practices, particularly in hospitals will offer lucrative opportunities to market players. The rising disposable income and large patient pool due to a lack of awareness regarding hygiene in emerging economies will drive sales in the market.
Increasing expenditure on healthcare services is leading to the emergence of more and new hospitals worldwide, which in turn, is spurring demand for hospital supplies.
Other factors such as the growth in nosocomial infections have not only increased the mortality and morbidity rate but also the healthcare burden by stretching the length of hospitalization. Therefore, organizations such as the CDC and WHO are putting immense efforts into layout guidelines and conducting vigorous studies to control the occurrence of hospital-acquired infections.
However, despite these efforts, there is still a significant rise in the prevalence of these infections. Thus, increasing research and development efforts to develop hygienic solutions in the hospital supplies industry to minimize exposure to infection and other viral diseases expect to uncap lucrative opportunities in the hospital supplies market.
Principal Consultant
Lack of awareness regarding hospital-acquired infection and hygiene in developing countries is contributing to the rapid rise of hospital-acquired infection in these countries. According to a study published in the Journal of Epidemiology and Community Health, more than 20% of all hospital-acquired infections are associated with intensive care unit visits.
Most emerging nations have about 2-3-fold higher hospital-acquired infection populations. Thus, the lack of awareness in developing countries regarding hospital-acquired infection and its diagnosis is projected to restrict the growth in the hospital-acquired infection testing market. This is expected to have a negative impact on sales of hospital supplies.
When most countries in the developed regions have strongly built health insurance coverage, these policies are less spread in developing countries. World Health Organization states that the world's partial population is not able to obtain essential health services.
According to a national survey, only one-fifth of the Indian population is insured under health insurance.
Most health insurance schemes do not cover disposables such as disposable gloves or masks utilized during surgical procedures. This adds to the overall cost imparted on the patient’s budget. Thus, the lack of proper health insurance that covers essential healthcare services and the cost of various hospital supplies in underdeveloped and developing countries may restrain the growth in the hospital supplies market.
Rising Demand for Wound Care Products in the USA to Fuel Growth
According to FMI, the USA is expected to dominate the North American hospital supplies market, with a total market share of 92.8% in 2021, and is projected to continue to exhibit high growth through 2022 & beyond.
According to CDC, approximately 5% of patients acquire hospital-associated infections in developed countries. Hence, rising in the number of patient admissions, high demand for treatment, and increased prevalence of hospital-acquired infection and adoption of medical hygiene practices will continue pushing sales in the USA.
Growth in the Medical Automation Market in Germany will Spur Demand for Hospital Supplies
Germany is set to exhibit growth at a CAGR of around 3.5% in the Europe hospital supplies market during the forecast period. Rising awareness of hospital-acquired infection and strong healthcare infrastructure, attractive reimbursement policies along with the best Research and Development performance in the industry will drive the growth of the hospital supplies market in Germany.
Expansion of the Portable Medical Devices Market in China Will Fuel Growth
Sales in the China market are projected to expand at a CAGR rate of 4.1% and hold about half of the East Asia hospital supplies market share and are expected to dominate throughout the forecast period, finds FMI.
Growing investments in research & development activities and technological advancements in the healthcare sector will drive sales in the market. China is expected to spearhead the growth in East Asia due to technological advancement, wide availability of consumable medical supply products, and the presence of numerous players in the healthcare sector.
Rising Demand for Sterile and Disposable Products Will Boost the India Market
Total demand in India accounted for 45.3% of the market share in 2021 and is projected to increase with a CAGR of 4.0% over the forecast period. Growing prevalence of antibacterial-resistant infections and hospital-acquired infections spurring demand for hospital supplies.
With rising expenditure on healthcare services, developing economies like India are focussing more on innovation and technology in the healthcare sector which is in turn fuelling the hospital supplies market within the country.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Sales of Hypodermic and Radiology Products to Remain High
Based on product type, the hypodermic and radiology products segment accounted for 17.6% of the global market share in 2021. Sales in this segment are forecast to increase at a CAGR of 3.6% over the forecast period. Products like needles and syringes are routinely used in hospitals or diagnostic labs for drawing blood or injecting medicines.
On the other hand, radiology equipment like X-ray machines and C-Arms which are often employed in routine diagnosis by doctors, especially during surgical procedures require related disposable products to avoid spreading the infection to patients.
Demand for Hospital Supplies in the Hospital Segment Will Gain Momentum
By end-user, the hospital segment held a market share of 47.2% in 2021, with sales poised to grow at a CAGR of 3.9% over the upcoming decade. Hospitals have a large patient population and are exposed to numerous viral infections. Thus, to minimize the prevalence of healthcare-associated infection, hospitals are focusing on maintaining a hygienic environment which in turn is spurring demand for hospital supplies.
The hospital supplies market is highly fragmented. There are numerous players in the global market involved in developing cutting-edge solutions for the development of efficient products that can meet their customer’s needs.
Leading hospital supplies manufacturers are focusing on mergers, acquisitions, collaborations, and new product launches to increase sales and expand their global footprint. They are also focusing on improving their market presence by expanding their product line across countries to capitalize on untapped opportunities. For instance:
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2017 to 2021 |
| Market Analysis | US$ Billion for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, the UK, Germany, France, Italy, Spain, Russia, BENELUX, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, North Africa, GCC Countries, Turkey, and South Africa |
| Key Market Segments Covered | Product, End User, and Region |
| Key Companies Profiled | GE Healthcare; Medtronic (Covidien); Thermo Fischer Scientific Inc.; Becton, Dickinson, and Company; Cardinal Heath; Boston Scientific Corporation; B. Braun Melsungen AG; 3M Science; Molnlycke Health Care AB; Advanced Sterilization Services; Terumo; Baxter; Kimberly-Clark Corporation; Steris Corporation; Stryker Corporation; Getinge AB; Johnson and Johnson |
The global hospital supplies market is expected to be worth US$ 29.5 Billion in 2022 and is set to expand by 1.4X over the next ten years.
The hospital supplies market is expected to reach US$ 42.3 Billion by end of 2032, exhibiting growth at a CAGR of 3.7% between 2022 and 2032.
Key trends influencing sales in the hospital supplies market include increasing adoption of advanced hospital supplies, higher consumption of hospital supplies and strategic collaborations, mergers, and acquisitions among key players.
South Asia is expected to lead the global market, contributing over 23% of the revenue share in 2021.
The U.S., Japan, China, Germany, and India are the top five countries, which are expected to drive demand in the hospital supplies market.
GE Healthcare, Medtronic (Covidien), Thermo Fischer Scientific Inc., Becton, Dickinson and Company, Cardinal Heath, Boston Scientific Corporation, B. Braun Melsungen AG, 3M Science, Molnlycke Health Care AB, Advanced Sterilization Services, Terumo, Baxter, Kimberly-Clark Corporation, Steris Corporation, Stryker Corporation, Getinge AB, Johnson and Johnson are the key manufacturers in this market.
1. Executive Summary | Hospital Supplies Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global Healthcare Expenditure Outlook
4.1.2. Growth of the Healthcare Sector in Emerging Nations
4.1.3. Global Market
4.2. Forecast Factors - Relevance & Impact
4.2.1. Usage of Disposable Supplies
4.2.2. Increase in Demand for Disposable Supplies
4.2.3. Impact of Covid
4.2.4. Strategic Collaborations
4.2.5. Frequency of Product Launches
4.2.6. Rise of healthcare spending in developing economies
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
5. COVID-19 Crisis Analysis
5.1. COVID-19 and Impact Analysis
5.1.1. Revenue By Product Type
5.1.2. Revenue By End User
5.1.3. Revenue By Region
5.2. 2021 Market Scenario
6. Key Success Factors
6.1. Product Adoption/ Usage Analysis
6.2. Product USPs/ features
6.3. Key Promotional Strategies, By Key Manufacturers
6.4. Regulatory Scenario
6.5. Reimbursement Scenario
6.6. Value Chain Analysis
7. Global Market Demand (in Value or Size in US$ Billion) Analysis 2017 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Value (US$ Billion) Analysis, 2017 to 2021
7.2. Current and Future Market Size (US$ Billion) and Forecast Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Billion) By Product Type, 2017 to 2021
8.3. Current and Future Market Size (US$ Billion) and Forecast By Product Type, 2022 to 2032
8.3.1. Sterilization Consumables
8.3.2. Wound Care Product
8.3.3. Dialysis Product
8.3.4. Infusion Product
8.3.5. Hypodermic & Radiology Product
8.3.6. Intubation & Respiratory Supplies
8.3.7. Surgical Procedure Kits & Trays
8.3.8. Blood Management & Diagnostic Supplies
8.3.9. General Disposable Product
8.4. Market Attractiveness Analysis By Product Type
9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Billion) By End User, 2017 to 2021
9.3. Current and Future Market Size (US$ Billion) and Forecast By End User, 2022 to 2032
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Clinics
9.3.4. Diagnostic Centers
9.3.5. Long-Term Care Centers
9.3.6. Nursing Facilities
9.4. Market Attractiveness Analysis By End User
10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Billion) and By Region, 2017 to 2021
10.3. Current and Future Market Size (US$ Billion) and Forecast By Region, 2022 to 2032
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. South Asia
10.3.5. East Asia
10.3.6. Oceania
10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
11.1. Introduction
11.2. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2017 to 2021
11.3. Current and Future Market Size (US$ Billion) and Forecast By Market Taxonomy, 2022 to 2032
11.3.1. By Country
11.3.1.1. United States of America
11.3.1.2. Canada
11.3.2. By Product Type
11.3.3. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Product Type
11.4.3. By End User
11.5. Market Trends
11.6. Key Market Participants - Intensity Mapping
11.7. Drivers and Restraints - Impact Analysis
11.8. Country-Level Analysis & Forecast
11.8.1. USA Market Analysis
11.8.1.1. Introduction
11.8.1.2. Market Analysis and Forecast by Market Taxonomy
11.8.1.2.1. By Product Type
11.8.1.2.2. By End User
11.8.2. Canada Market Analysis
11.8.2.1. Introduction
11.8.2.2. Market Analysis and Forecast by Market Taxonomy
11.8.2.2.1. By Product Type
11.8.2.2.2. By End User
12. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
12.1. Introduction
12.2. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2017 to 2021
12.3. Current and Future Market Size (US$ Billion) and Forecast By Market Taxonomy, 2022 to 2032
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Product Type
12.3.3. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product Type
12.4.3. By End User
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country-Level Analysis & Forecast
12.8.1. Brazil Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast by Market Taxonomy
12.8.1.2.1. By Product Type
12.8.1.2.2. By End User
12.8.2. Mexico Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast by Market Taxonomy
12.8.2.2.1. By Product Type
12.8.2.2.2. By End User
12.8.3. Argentina Market Analysis
12.8.3.1. Introduction
12.8.3.2. Market Analysis and Forecast by Market Taxonomy
12.8.3.2.1. By Product Type
12.8.3.2.2. By End User
13. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032
13.1. Introduction
13.2. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2017 to 2021
13.3. Current and Future Market Size (US$ Billion) and Forecast By Market Taxonomy, 2022 to 2032
13.3.1. By Country
13.3.1.1. United Kingdom
13.3.1.2. Germany
13.3.1.3. France
13.3.1.4. Italy
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Russia
13.3.1.8. Rest of Europe
13.3.2. By Product Type
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product Type
13.4.3. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country-Level Analysis & Forecast
13.8.1. UK Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product Type
13.8.1.2.2. By End User
13.8.2. Germany Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product Type
13.8.2.2.2. By End User
13.8.3. France Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast by Market Taxonomy
13.8.3.2.1. By Product Type
13.8.3.2.2. By End User
13.8.4. Italy Market Analysis
13.8.4.1. Introduction
13.8.4.2. Market Analysis and Forecast by Market Taxonomy
13.8.4.2.1. By Product Type
13.8.4.2.2. By End User
13.8.5. Spain Market Analysis
13.8.5.1. Introduction
13.8.5.2. Market Analysis and Forecast by Market Taxonomy
13.8.5.2.1. By Product Type
13.8.5.2.2. By End User
13.8.6. BENELUX Market Analysis
13.8.6.1. Introduction
13.8.6.2. Market Analysis and Forecast by Market Taxonomy
13.8.6.2.1. By Product Type
13.8.6.2.2. By End User
13.8.7. Russia Market Analysis
13.8.7.1. Introduction
13.8.7.2. Market Analysis and Forecast by Market Taxonomy
13.8.7.2.1. By Product Type
13.8.7.2.2. By End User
14. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Historical Market Size (US$ Billion) and Trend Analysis & Forecast By Market Taxonomy, 2017 to 2021
14.3. Current and Future Market Size (US$ Billion) and Forecast By Market Taxonomy, 2022 to 2032
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Indonesia
14.3.1.4. Malaysia
14.3.1.5. Rest of South Asia
14.3.2. By Product Type
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product Type
14.4.3. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country-Level Analysis & Forecast
14.8.1. India Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product Type
14.8.1.2.2. By End User
14.8.2. Indonesia Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product Type
14.8.2.2.2. By End User
14.8.3. Malaysia Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product Type
14.8.3.2.2. By End User
14.8.4. Thailand Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast by Market Taxonomy
14.8.4.2.1. By Product Type
14.8.4.2.2. By End User
15. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2017 to 2021
15.3. Current and Future Market Size (US$ Billion) and Forecast By Market Taxonomy, 2022 to 2032
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product Type
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product Type
15.4.3. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country-Level Analysis & Forecast
15.8.1. China Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product Type
15.8.1.2.2. By End User
15.8.2. Japan Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product Type
15.8.2.2.2. By End User
15.8.3. South Korea Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product Type
15.8.3.2.2. By End User
16. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2017 to 2021
16.3. Current and Future Market Size (US$ Billion) and Forecast By Market Taxonomy, 2022 to 2032
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Product Type
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Product Type
16.4.2. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country-Level Analysis & Forecast
16.8.1. Australia Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product Type
16.8.1.2.2. By End User
16.8.2. New Zealand Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product Type
16.8.2.2.2. By End User
17. Middle East & Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.2. Historical Market Size (US$ Billion) and Trend Analysis & Forecast By Market Taxonomy, 2017 to 2021
17.3. Current and Future Market Size (US$ Billion) and Forecast By Market Taxonomy, 2022 to 2032
17.3.1. By Country
17.3.1.1. Turkey
17.3.1.2. GCC Countries
17.3.1.3. North Africa
17.3.1.4. South Africa
17.3.1.5. Rest of MEA
17.3.2. By Product Type
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product Type
17.4.3. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country-Level Analysis & Forecast
17.8.1. Turkey Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product Type
17.8.1.2.2. By End User
17.8.2. GCC Countries Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product Type
17.8.2.2.2. By End User
17.8.3. North Africa Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product Type
17.8.3.2.2. By End User
17.8.4. South Africa Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Product Type
17.8.4.2.2. By End User
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional Footprint of Players
18.4.2. Product Footprint by Players
18.4.3. Channel Footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1.1. GE Healthcare
19.3.1.1.1. Overview
19.3.1.1.2. Component Portfolio
19.3.1.1.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.1.4. Sales Footprint
19.3.1.1.5. Strategy Overview
19.3.1.1.5.1. Marketing Strategies
19.3.1.1.5.2. Channel Strategies
19.3.1.1.5.3. Product Strategies
19.3.1.2. Medtronic (Covidien)
19.3.1.2.1. Overview
19.3.1.2.2. Component Portfolio
19.3.1.2.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.2.4. Sales Footprint
19.3.1.2.5. Strategy Overview
19.3.1.2.5.1. Marketing Strategies
19.3.1.2.5.2. Channel Strategies
19.3.1.2.5.3. Product Strategies
19.3.1.3. Thermo Fischer Scientific Inc.
19.3.1.3.1. Overview
19.3.1.3.2. Component Portfolio
19.3.1.3.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.3.4. Sales Footprint
19.3.1.3.5. Strategy Overview
19.3.1.3.5.1. Marketing Strategies
19.3.1.3.5.2. Channel Strategies
19.3.1.3.5.3. Product Strategies
19.3.1.4. Becton, Dickinson, and Company
19.3.1.4.1. Overview
19.3.1.4.2. Component Portfolio
19.3.1.4.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.4.4. Sales Footprint
19.3.1.4.5. Strategy Overview
19.3.1.4.5.1. Marketing Strategies
19.3.1.4.5.2. Channel Strategies
19.3.1.4.5.3. Product Strategies
19.3.1.5. Cardinal Heath
19.3.1.5.1. Overview
19.3.1.5.2. Component Portfolio
19.3.1.5.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.5.4. Sales Footprint
19.3.1.5.5. Strategy Overview
19.3.1.5.5.1. Marketing Strategies
19.3.1.5.5.2. Channel Strategies
19.3.1.5.5.3. Product Strategies
19.3.1.6. Boston Scientific Corporation
19.3.1.6.1. Overview
19.3.1.6.2. Component Portfolio
19.3.1.6.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.6.4. Sales Footprint
19.3.1.6.5. Strategy Overview
19.3.1.6.5.1. Marketing Strategies
19.3.1.6.5.2. Channel Strategies
19.3.1.6.5.3. Product Strategies
19.3.1.7. B. Braun Melsungen AG
19.3.1.7.1. Overview
19.3.1.7.2. Component Portfolio
19.3.1.7.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.7.4. Sales Footprint
19.3.1.7.5. Strategy Overview
19.3.1.7.5.1. Marketing Strategies
19.3.1.7.5.2. Channel Strategies
19.3.1.7.5.3. Product Strategies
19.3.1.8. 3M Science
19.3.1.8.1. Overview
19.3.1.8.2. Component Portfolio
19.3.1.8.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.8.4. Sales Footprint
19.3.1.8.5. Strategy Overview
19.3.1.8.5.1. Marketing Strategies
19.3.1.8.5.2. Channel Strategies
19.3.1.8.5.3. Product Strategies
19.3.1.9. Molnlycke Health Care AB
19.3.1.9.1. Overview
19.3.1.9.2. Component Portfolio
19.3.1.9.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.9.4. Sales Footprint
19.3.1.9.5. Strategy Overview
19.3.1.9.5.1. Marketing Strategies
19.3.1.9.5.2. Channel Strategies
19.3.1.9.5.3. Product Strategies
19.3.1.10. Advanced Sterilization Services
19.3.1.10.1. Overview
19.3.1.10.2. Component Portfolio
19.3.1.10.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.10.4. Sales Footprint
19.3.1.10.5. Strategy Overview
19.3.1.10.5.1. Marketing Strategies
19.3.1.10.5.2. Channel Strategies
19.3.1.10.5.3. Product Strategies
19.3.1.11. Terumo
19.3.1.11.1. Overview
19.3.1.11.2. Component Portfolio
19.3.1.11.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.11.4. Sales Footprint
19.3.1.11.5. Strategy Overview
19.3.1.11.5.1. Marketing Strategies
19.3.1.11.5.2. Channel Strategies
19.3.1.11.5.3. Product Strategies
19.3.1.12. Baxter
19.3.1.12.1. Overview
19.3.1.12.2. Component Portfolio
19.3.1.12.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.12.4. Sales Footprint
19.3.1.12.5. Strategy Overview
19.3.1.12.5.1. Marketing Strategies
19.3.1.12.5.2. Channel Strategies
19.3.1.12.5.3. Product Strategies
19.3.1.13. Kimberly-Clark Corporation
19.3.1.13.1. Overview
19.3.1.13.2. Component Portfolio
19.3.1.13.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.13.4. Sales Footprint
19.3.1.13.5. Strategy Overview
19.3.1.13.5.1. Marketing Strategies
19.3.1.13.5.2. Channel Strategies
19.3.1.13.5.3. Product Strategies
19.3.1.14. Steris Corporation
19.3.1.14.1. Overview
19.3.1.14.2. Component Portfolio
19.3.1.14.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.14.4. Sales Footprint
19.3.1.14.5. Strategy Overview
19.3.1.14.5.1. Marketing Strategies
19.3.1.14.5.2. Channel Strategies
19.3.1.14.5.3. Product Strategies
19.3.1.15. Stryker Corporation
19.3.1.15.1. Overview
19.3.1.15.2. Component Portfolio
19.3.1.15.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.15.4. Sales Footprint
19.3.1.15.5. Strategy Overview
19.3.1.15.5.1. Marketing Strategies
19.3.1.15.5.2. Channel Strategies
19.3.1.15.5.3. Product Strategies
19.3.1.16. Getinge AB
19.3.1.16.1. Overview
19.3.1.16.2. Component Portfolio
19.3.1.16.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.16.4. Sales Footprint
19.3.1.16.5. Strategy Overview
19.3.1.16.5.1. Marketing Strategies
19.3.1.16.5.2. Channel Strategies
19.3.1.16.5.3. Product Strategies
19.3.1.17. Johnson and Johnson
19.3.1.17.1. Overview
19.3.1.17.2. Component Portfolio
19.3.1.17.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.17.4. Sales Footprint
19.3.1.17.5. Strategy Overview
19.3.1.17.5.1. Marketing Strategies
19.3.1.17.5.2. Channel Strategies
19.3.1.17.5.3. Product Strategies
20. Assumptions and Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Hospital Supplies Market
